Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples With Implications for Alzheimer's Disease Risk
Launched by UNIVERSITY OF UTAH · Oct 17, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The "Nuestro Sueno" clinical trial is studying a special program designed to help Latino couples where one partner has been diagnosed with sleep apnea. Sleep apnea is a condition that causes breathing problems during sleep, and one common treatment involves using a device called positive airway pressure (PAP). This trial aims to see if the culturally adapted couples intervention improves how well the patient uses their PAP device and if it helps both partners sleep better. Researchers will also look at whether this program enhances overall quality of life and memory for both partners.
To participate in the trial, individuals must be Latino, over 35 years old, and diagnosed with sleep apnea. They should be married or living with a partner for over a year, and both partners need to be able to read or write in English or Spanish. Participants will receive support through telehealth, which means they can join the program from home using their phones or the internet. The trial is currently recruiting, and it offers a chance for couples to work together to improve their sleep health and overall well-being.
Gender
ALL
Eligibility criteria
- Patients inclusion criteria:
- • Self-reported Latino ethnicity
- • Age \>35, 3)
- • Diagnosed with obstructive sleep apnea and intend to start PAP
- • Never used positive airway pressure or-restarting CPAP after 3 months
- • Married or cohabiting with a romantic partner for \>1 year
- • Able to read/write English or Spanish
- • Access to cellular (active data plan) or Wi-Fi, or able to use study devices in order to complete the telehealth intervention.
- Partner inclusion criteria:
- • Able to read/write in English or Spanish
- • Interested in improving their sleep (yes/no)
- • Access to cellular (active data plan) or Wi-Fi, to complete the telehealth intervention or able to use a study device.
- • Partners of all ethnicities will be invited to participate. The intervention will be delivered in couples preferred language.
- • Exclusion criteria for both patient and partner
- • High risk or presence of moderate to severe comorbid sleep disorders (i.e., restless legs syndrome)
- • History of cognitive or neurological or major psychiatric disorders
- • Unstable or serious medical illness that would interfere with participation (cancer, renal disease on dialysis, moderate to severe chronic obstructive pulmonary disease
- • Patients with need for more complex care (e.g., adaptive servo-ventilation, supplemental oxygen) or concurrent sleep apnea treatment such as bariatric surgery or oral appliance
- • Overnight work \> 1x per month; 7) Pregnancy/desire to become pregnant in the study period; 8) Current participation in behavioral sleep treatment (e.g., cognitive behavioral therapy for insomnia)
- • Concurrent participation in another clinical trial
- • Caregiving for an infant \< 2 years old or adult who requires overnight assistance
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Tucson, Arizona, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported